Skip to main content

. 1985 Aug;48(8):842–843. doi: 10.1136/jnnp.48.8.842

Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.

S Jegou, F Javoy-Agid, C Delbende, M Ruberg, H Vaudry, Y Agid

PMCID: PMC1028461 PMID: 4031938

842

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Dubois B., Ruberg M., Javoy-Agid F., Ploska A., Agid Y. A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res. 1983 Dec 12;288(1-2):213–218. doi: 10.1016/0006-8993(83)90096-3. [DOI] [PubMed] [Google Scholar]
Emson P. C., Fahrenkrug J., Spokes E. G. Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease. Brain Res. 1979 Sep 7;173(1):174–178. doi: 10.1016/0006-8993(79)91109-0. [DOI] [PubMed] [Google Scholar]
Epelbaum J., Ruberg M., Moyse E., Javoy-Agid F., Dubois B., Agid Y. Somatostatin and dementia in Parkinson's disease. Brain Res. 1983 Nov 14;278(1-2):376–379. doi: 10.1016/0006-8993(83)90277-9. [DOI] [PubMed] [Google Scholar]
Hakim A. M., Mathieson G. Dementia in Parkinson disease: a neuropathologic study. Neurology. 1979 Sep;29(9 Pt 1):1209–1214. doi: 10.1212/wnl.29.9_part_1.1209. [DOI] [PubMed] [Google Scholar]
Leboulenger F., Leroux P., Delarue C., Tonon M. C., Charnay Y., Dubois P. M., Coy D. H., Vaudry H. Co-localization of vasoactive intestinal peptide (VIP) and enkephalins in chromaffin cells of the adrenal gland of amphibia. Stimulation of corticosteroid production by VIP. Life Sci. 1983 Jan 24;32(4):375–383. doi: 10.1016/0024-3205(83)90083-8. [DOI] [PubMed] [Google Scholar]
Marttila R. J., Rinne U. K. Dementia in Parkinson's disease. Acta Neurol Scand. 1976 Nov;54(5):431–441. doi: 10.1111/j.1600-0404.1976.tb04375.x. [DOI] [PubMed] [Google Scholar]
Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet. 1977 Jan 22;1(8004):189–189. doi: 10.1016/s0140-6736(77)91780-9. [DOI] [PubMed] [Google Scholar]
Rossor M., Fahrenkrug J., Emson P., Mountjoy C., Iversen L., Roth M. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide. Brain Res. 1980 Nov 10;201(1):249–253. doi: 10.1016/0006-8993(80)90795-7. [DOI] [PubMed] [Google Scholar]
Ruberg M., Ploska A., Javoy-Agid F., Agid Y. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia. Brain Res. 1982 Jan 28;232(1):129–139. doi: 10.1016/0006-8993(82)90615-1. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES